Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery
Launched by KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE, JEDDAH · Mar 12, 2017
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
Hypothesis :
Custodial is not inferior to blood cardioplegia in myocardial protection in paediatric cardiac surgery ..
Methodology :
Study design :
Randomized controlled trial
Data collection:
All demographic data ,diagnosis ,procedure(type.CPB time ,crossclamp time) , surgeon and hospital course details .
Computer generated randomisation into two groups based on cardioplegia solution .
if randomised to blood patient will receive blood cardioplegia, delivered by microplegia delivery system by adding potassium to the blood (K= 35 ml eq/L) . The initial dose will be 35ml/ kg, and subs...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All paediatric patients referred to our hospital which will undergo open cardiac repair with cardiopulmonary bypass and cardioplegic arrest .
- Exclusion Criteria:
- • All emergency procedure( require immediate surgery)
- • Cases that don't require use of cardioplegia .
About King Faisal Specialist Hospital & Research Centre, Jeddah
King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Jeddah is a premier healthcare institution renowned for its commitment to excellence in patient care, medical research, and education. As a leading sponsor of clinical trials, KFSH&RC leverages cutting-edge technology and a multidisciplinary approach to advance medical knowledge and improve treatment outcomes. The institution is dedicated to conducting high-quality research that adheres to international standards, fostering innovation in various fields of medicine while ensuring the highest ethical standards and patient safety. With a robust infrastructure and a team of experienced professionals, KFSH&RC is at the forefront of transforming healthcare through research and clinical excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jeddah, Western, Saudi Arabia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials